VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1 SIGNALING AS A NOVEL MECHANISM OF T CELL SUPPRESSION IN TUMOR NEOANGIOGENESIS
The immunomodulatory activity of vascular endothelial growth factors (VEGFs) reveals a new role of neoangiogenesis in tumor development. Most of VEGF effects on T cells are mediated through the VEGF-R2 receptors. Placental growth factor (PlGF) belongs to the VEGFs family and is a selective ligand fo...
Guardado en:
Autores principales: | E. R. Chernykh, O. Yu. Leplina, M. A. Tikhonova, E. V. Batorov, A. A. Ostanin |
---|---|
Formato: | article |
Lenguaje: | RU |
Publicado: |
SPb RAACI
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c85851d822a14a219263bda43e1b113b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
REC8 suppresses tumor angiogenesis by inhibition of NF-κB-mediated vascular endothelial growth factor expression in gastric cancer cells
por: Liu,Miao, et al.
Publicado: (2020) -
Efecto del factor de crecimiento endotelio vascular (VEGF) sobre perforaciones timpánicas en ratas Long-Evans
por: Zúñiga P,Jorge, et al.
Publicado: (2007) -
Safety of high-dose intravitreal triamcinolone acetonide as low-cost alternative to anti-vascular endothelial growth factor agents in lower-middle-income countries
por: Ghoraba HH, et al.
Publicado: (2018) -
Vascular endothelial growth factor in the fluid of the anterior chamber of the eye in patients with diabetic retinopathy, cataract andneovascular glaucoma
por: Anatoliy Gennad'evich Kuz'min, et al.
Publicado: (2010) -
Expression of endothelin in experimental myocardial infarction in a changed concentration of FGF and VEGF
por: M. G. Shurygin, et al.
Publicado: (2013)